Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

PROSHARES TRUST (ZBIO) Profit After Tax: 2023-2024

Historic Profit After Tax for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to -$157.0 million.

  • Zenas BioPharma's Profit After Tax fell 33.40% to -$51.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$189.9 million, marking a year-over-year decrease of 47.24%. This contributed to the annual value of -$157.0 million for FY2024, which is 322.91% down from last year.
  • Zenas BioPharma's Profit After Tax amounted to -$157.0 million in FY2024, which was down 322.91% from -$37.1 million recorded in FY2023.
  • In the past 5 years, Zenas BioPharma's Profit After Tax registered a high of -$37.1 million during FY2023, and its lowest value of -$157.0 million during FY2024.
  • In the last 2 years, Zenas BioPharma's Profit After Tax had a median value of -$97.1 million in 2023 and averaged -$97.1 million.
  • Data for Zenas BioPharma's Profit After Tax shows a maximum YoY slumped of 322.91% (in 2024) over the last 5 years.
  • Over the past 2 years, Zenas BioPharma's Profit After Tax (Yearly) stood at -$37.1 million in 2023, then slumped by 322.91% to -$157.0 million in 2024.